The FDA has designated Otulfi (ustekinumab-aauz) as an interchangeable biosimilar to the reference product Stelara ...

In a US cohort study, hospital inpatient diversity was linked to improved gastrointestinal outcomes in Hispanic and Native American patients.

In patients with Barrett esophagus, EAC significantly increased all-cause mortality, but rates remained elevated after excluding EAC-related deaths.

GLP-1 RAs are associated with a significant decrease in apnea-hypopnea index among patients with moderate to severe OSA and without diabetes.

Novo Nordisk is teaming up with Septerna to develop new pills to treat obesity, type 2 diabetes, and other metabolic diseases.

Sarcopenia in the United States appears to be correlated to gallstone risk, most significantly among women, according to study results published in BMC Gastroenterology.

In adults with nonalcoholic fatty liver disease and obesity, the estimated glucose disposal rate strongly negatively correlated with liver fibrosis severity.

Autoantibodies positivity was associated with a shorter time to diabetes development among children with acute and chronic pancreatitis.

The FDA has announced that it is taking steps to remove concentrated ingestible fluoride prescription drug products for children from the market.

A new report says rice sold in US stores contains toxic heavy metals, including arsenic, cadmium, lead, and mercury.

House Republicans have proposed cuts to Medicaid funding, which could be devastating to America’s rural hospitals.

Dupixent (dupilumab) Interleukin-4 receptor alpha antagonist Treatment of patients aged 12 years and older with chronic spontaneous urticaria who remain symptomatic despite H1 antihistamine treatment.